Welcome to GenPrice! Check out our latest updates.

Shopping Cart (0)

Your cart is empty

Add some products to get started!

CCR5 antagonist 2

CCR5 antagonist 2 (Compound 25) is a CCR5 antagonist with an IC50 of 8.34 nM. CCR5 antagonist 2 shows broad-spectrum anti-HIV-1 activities[1].

Product Specifications

CAS Number

1800570-93-7

UNSPSC

12352005

Target

CCR; HIV

Type

Reference compound

Related Pathways

Anti-infection; GPCR/G Protein; Immunology/Inflammation

Applications

COVID-19-anti-virus

Field of Research

Infection

Assay Protocol

https://www.medchemexpress.com/ccr5-antagonist-2.html

Solubility

10 mM in DMSO

Smiles

CC1=NC2=C(N1[C@H]3C[C@H]4N(CC[C@@H](C5=CSC=C5)NC(C6CCC(F)(CC6)F)=O)[C@@H](C3)CC4)CCN(C2)C(C(C)C)=O

Molecular Formula

C32H45F2N5O2S

Molecular Weight

601.79

References & Citations

[1]Xie X, et al. Structure-Based Design of Tropane Derivatives as a Novel Series of CCR5 Antagonists with Broad-Spectrum Anti-HIV-1 Activities and Improved Oral Bioavailability. J Med Chem. 2022 Dec 22;65 (24) :16526-16540.

Shipping Conditions

Room temperature

Scientific Category

Reference compound1

Clinical Information

No Development Reported

Isoform

CCR5; HIV-1

Frequently Asked Questions

More Discoveries

Explore Other Products

Browse additional items from our catalog

Amdinocillin (~85%)
TRC-A576405-500MG 500 mg

Amdinocillin (~85%)

Sign In for Pricing
View Details
CXCL5 (NM_002994) Human Over-expression Lysate
LY401049 100 µg

CXCL5 (NM_002994) Human Over-expression Lysate

Sign In for Pricing
View Details
Tau (Ab-404) Antibody
8B7242-AAT 50 µg

Tau (Ab-404) Antibody

Sign In for Pricing
View Details
DLL3 Human Gene Knockout Kit (CRISPR)
KN400005 1 Kit

DLL3 Human Gene Knockout Kit (CRISPR)

Sign In for Pricing
View Details
Tissue Total RNA, Pancreas
CR561769 5 µg

Tissue Total RNA, Pancreas

Sign In for Pricing
View Details
PAX5 / BSAP (Early B-Cell Marker) (PCRP-PAX5-1B7), 0.2mg/mL
BNUB1908-500 1x 500 µL

PAX5 / BSAP (Early B-Cell Marker) (PCRP-PAX5-1B7), 0.2mg/mL

Sign In for Pricing
View Details